Innovative Medical Management Co.,Ltd.

SZSE:002173 Stock Report

Market Cap: CN¥3.7b

Innovative Medical ManagementLtd Past Earnings Performance

Past criteria checks 0/6

Innovative Medical ManagementLtd has been growing earnings at an average annual rate of 17.3%, while the Healthcare industry saw earnings growing at 6.7% annually. Revenues have been declining at an average rate of 7.1% per year.

Key information

17.3%

Earnings growth rate

17.2%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate-7.1%
Return on equity-4.0%
Net Margin-9.7%
Next Earnings Update27 Apr 2024

Recent past performance updates

Recent updates

Innovative Medical Management Co.,Ltd.'s (SZSE:002173) 30% Share Price Surge Not Quite Adding Up

Mar 08
Innovative Medical Management Co.,Ltd.'s (SZSE:002173) 30% Share Price Surge Not Quite Adding Up

Revenue & Expenses Breakdown
Beta

How Innovative Medical ManagementLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002173 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 23776-751210
30 Jun 23779-291210
31 Mar 23743-621220
31 Dec 22710-741160
30 Sep 22718-801340
30 Jun 22679-1301250
31 Mar 22721-941160
01 Jan 22712-1031260
30 Sep 21736-3011100
30 Jun 21777-2831170
31 Mar 21733-3021360
31 Dec 20724-3151310
30 Sep 20677-1,139142-1
30 Jun 20701-1,1631640
31 Mar 20786-1,2201730
31 Dec 19872-1,1501870
30 Sep 19930-1461622
30 Jun 19997-891751
31 Mar 191,012291803
31 Dec 181,006381733
30 Sep 181,0281811825
30 Jun 189421821514
31 Mar 188851731303
31 Dec 178411541213
30 Sep 178031431110
30 Jun 177851161050
31 Mar 177541101030
31 Dec 16763115960
30 Sep 1658419970
30 Jun 164338760
31 Mar 16294-30600
31 Dec 15137-65500
30 Sep 15147-31450
30 Jun 15150-36520
31 Mar 15167-25490
31 Dec 14183-11510
30 Sep 14205-3520
30 Jun 142207530
31 Mar 1426920520
31 Dec 1329924510
30 Sep 1332339580
30 Jun 1335342540

Quality Earnings: 002173 is currently unprofitable.

Growing Profit Margin: 002173 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002173 is unprofitable, but has reduced losses over the past 5 years at a rate of 17.3% per year.

Accelerating Growth: Unable to compare 002173's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 002173 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-2.6%).


Return on Equity

High ROE: 002173 has a negative Return on Equity (-3.97%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.